眼科新进展2024，Vol.44Issue(1)：71-75,5.DOI:10.13389/j.cnki.rao.2024.0014
钠-葡萄糖协同转运蛋白2抑制剂治疗糖尿病视网膜病变的研究进展
Research progress of sodium-glucose cotransporter 2 inhibitors in the treat-ment of diabetic retinopathy
摘要
Abstract
Diabetic retinopathy(DR)is a common complication of diabetes.Sodium-glucose cotransporter 2(SGLT-2)inhibitors are widely used in diabetic patients as hypoglycemic drugs and also play a role in the prevention and treatment of DR.At present,there has been no systematic study on the clinical treatment of DR by SGLT-2 inhibitors.This paper re-views the research progress of SGLT-2 inhibitors in the treatment of DR,in order to provide more ideas for the clinical treatment of DR.关键词
钠-葡萄糖协同转运蛋白2抑制剂/糖尿病视网膜病变/研究进展Key words
sodium-glucose cotransporter 2 inhibitors/diabetic retinopathy/research progress分类
临床医学引用本文复制引用
邹蔚文,雷茹雪,黄慧,郑燕林..钠-葡萄糖协同转运蛋白2抑制剂治疗糖尿病视网膜病变的研究进展[J].眼科新进展,2024,44(1):71-75,5.基金项目
四川省科技攻关计划项目(编号:2021MS124) （编号:2021MS124）
